Interpace Biosciences Inc. Unveils Preliminary 2024 Financials Amid Stock Volatility
Interpace Biosciences Inc. has released preliminary 2024 financials, showing significant volatility in its stock price, with a recent close of $0.68 USD.
2 minutes to read